Letters Metal-on-metal hip implants

UK quality assurance of blood cobalt and chromium after hip implants

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e4017 (Published 12 June 2012) Cite this as: BMJ 2012;344:e4017
  1. Chris F Harrington, principal healthcare scientist and scheme manager1,
  2. Andrew Taylor, consultant clinical biochemist and scheme director1
  1. 1TEQAS, Faculty of Health and Medical Science, University of Surrey, Guildford GU2 7XH, UK
  1. chris.harrington1{at}nhs.net

In 2010 the Medicines and Healthcare Products Regulatory Agency (MHRA) issued a medical device alert recommending measurement of cobalt and chromium concentrations in blood from patients experiencing discomfort or pain associated with metal-on-metal hip prostheses.1 2 This followed concerns relating to possible adverse effects of metal released from the implants. A second alert updated the advice and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial